Abstract
The two types of lymphocytes, B and T, which are, respectively, responsible for humoral and cell-mediated immunity, express membrane receptors in relation to their immune functions: their task involves antigen recognition and elaboration of appropriate responses. Toward a multitude of possible antigens, a huge diversity in recognition structures is necessary: it is represented by the membrane immunoglobulins in charge of their binding. Contrasting to this diversity is the relative uniformity of receptor-associated proteins that are in charge of the elaboration of the response and are bound to the receptor itself by non-covalent bonds. Downstream the receptor complex, several pathways that have been studied in other chapters may be implemented to regulate lymphocyte proliferation and migration; they mainly involve the activation of cytoplasmic kinases, the generation of second messengers and the activation of small G-proteins.
We cannot summarise all immunology in a single chapter, but only extract some information related to the modalities of lymphocyte signalling, from receptors to effectors, trying to identify the features that cancer cells can utilise to reach their own goals and how these features can serve as potential targets for anticancer treatments.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsFurther Reading
Anders K, Blankenstein T. Molecular pathways: comparing the effects of drugs and T cells to effectively target oncogenes. Clin Cancer Res. 2013;19:320–6.
Brezski RJ, Monroe JG. B-cell receptor. Adv Exp Med Biol. 2008;640:12–21.
Burbach BJ, Medeiros RB, Mueller KL, Shimizu Y. T-cell receptor signaling to integrins. Immunol Rev. 2007;218:65–81.
Ceeraz S, Nowak EC, Noelle RJ. B7 family checkpoint regulators in immune regulation and disease. Trends Immunol. 2013;34:556–63.
Cronin SJ, Penninger JM. From T-cell activation signals to signaling control of anti-cancer immunity. Immunol Rev. 2007;220:151–68.
Dal Porto JM, Gauld SB, Merrell KT, Mills D, Pugh-Bernard AE, Cambier J. B-cell antigen receptor signaling. Mol Immunol. 2004;41:599–613.
Gomez-Rodriguez J, Readinger JA, Viorritto IC, Mueller KL, Houghtling RA, Schwartzberg PL. Tec kinases, actin, and cell adhesion. Immunol Rev. 2007;218:45–64.
Hendriks RW, Yuvaraj S, Kil LP. Targeting Bruton’s tyrosine kinase in B cell malignancies. Nat Rev Cancer. 2014;14:219–32.
Katzav S. Flesh and blood: the story of Vav1, a gene that signals in hematopoietic cells but can be transforming in human malignancies. Cancer Lett. 2007;255:241–54.
Kershaw MH, Westwood JA, Darcy PK. Gene-engineered T cells for cancer therapy. Nat Rev Cancer. 2013;13:525–41.
Kirkwood JM, Tarhini AA, Panelli MC, Moschos SJ, Zarour HM, Butterfield LH, Gogas HJ. Next generation of immunotherapy for melanoma. J Clin Oncol. 2008;26:3445–55.
Küppers R. Mechanisms of B-cell lymphoma pathogenesis. Nat Rev Cancer. 2005;5:251–62.
Peggs KS, Quezada SA, Allison JP. Cell intrinsic mechanisms of T-cell inhibition and application to cancer therapy. Immunol Rev. 2008;224:141–65.
Rojo JM, Bello R, Portolés P. T-cell receptor. Adv Exp Med Biol. 2008;640:1–11.
Smith-Garvin JE, Koretzky GA, Jordan MS. T-cell activation. Annu Rev Immunol. 2009;27:591–619.
Xue S, Gillmore R, Downs A, Tsallios A, Holler A, Gao L, Wong V, Morris E, Stauss HJ. Exploiting T-cell receptor genes for cancer immunotherapy. Clin Exp Immunol. 2005;139:167–72.
Yao S, Zhu Y, Chen L. Advances in targeting cell surface signalling molecules for immune modulation. Nat Rev Drug Discov. 2013;12:130–46.
Young RM, Staudt LM. Targeting pathological B cell receptor signalling in lymphoid malignancies. Nat Rev Drug Discov. 2013;12:229–43.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Robert, J. (2015). Lymphocyte Receptor Pathways. In: Textbook of Cell Signalling in Cancer. Springer, Cham. https://doi.org/10.1007/978-3-319-14340-8_13
Download citation
DOI: https://doi.org/10.1007/978-3-319-14340-8_13
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-14339-2
Online ISBN: 978-3-319-14340-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)